raffinose and Pneumothorax

raffinose has been researched along with Pneumothorax* in 1 studies

Other Studies

1 other study(ies) available for raffinose and Pneumothorax

ArticleYear
Evolving strategies in lung transplantation for emphysema.
    The Annals of thoracic surgery, 1994, Volume: 57, Issue:6

    Evolving strategies of pulmonary preservation, bronchial revascularization, immunosuppression, and infectious disease management were used in 15 initial consecutive patients undergoing lung transplantation for emphysema. There were 10 women and 5 men with a mean age of 49 years (range, 36 to 60 years). All patients required supplemental oxygen therapy. One bilateral, 9 left, and 5 right transplantations were performed. Mean preoperative forced expiratory volume in 1 second and total lung capacity were 16% and 146%, respectively, of predicted. Quadruple drug immunosuppression was used. Actuarial 1-year survival in this initial series is 93.3% +/- 6.4% (Kaplan-Meier) with one early cardiac death at day 71. Mean forced expiratory volume in 1 second and diffusing capacity for carbon monoxide at discharge were 43% and 62%, respectively, of predicted. Rehabilitation has been excellent, and all survivors are active and free of supplemental oxygen. During the study, the following treatment strategies have evolved: (1) University of Wisconsin solution has replaced Euro-Collins' solution for pulmonary preservation; (2) direct bronchial revascularization with the internal thoracic artery now is used; (3) an algorithm-based variable dose OKT3 induction regimen has resulted in a major reduction in dosage; and (4) infectious disease management focuses on the prophylaxis of cytomegalovirus and fungal infection using prolonged ganciclovir and early itraconazole therapy as well as the avoidance of Epstein-Barr virus mismatches. Single-lung transplantation for emphysema has excellent early results with continuing evolving management strategies.

    Topics: Adenosine; Adolescent; Adult; Allopurinol; Anastomosis, Surgical; Bronchi; Bronchial Arteries; Exercise Tolerance; Female; Forced Expiratory Volume; Glutathione; Graft Rejection; Humans; Hypertonic Solutions; Insulin; Lung Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Organ Preservation Solutions; Oxygen; Oxygen Inhalation Therapy; Pneumothorax; Pulmonary Diffusing Capacity; Pulmonary Emphysema; Raffinose; Surgical Wound Infection; Survival Rate; Tissue Preservation

1994